Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 16251-45-9 | MDL No. : | MFCD00066226 |
Formula : | C10H11NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PPIBJOQGAJBQDF-CBAPKCEASA-N |
M.W : | 177.20 | Pubchem ID : | 853161 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 52.11 |
TPSA : | 38.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.19 cm/s |
Log Po/w (iLOGP) : | 1.65 |
Log Po/w (XLOGP3) : | 1.68 |
Log Po/w (WLOGP) : | 1.15 |
Log Po/w (MLOGP) : | 1.42 |
Log Po/w (SILICOS-IT) : | 1.62 |
Consensus Log Po/w : | 1.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.27 |
Solubility : | 0.946 mg/ml ; 0.00534 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.1 |
Solubility : | 1.41 mg/ml ; 0.00795 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.83 |
Solubility : | 0.261 mg/ml ; 0.00147 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.61 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P273-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335-H412 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 156474-22-5 ]
tert-Butyl ((R)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate
Similarity: 0.88
[ 478646-28-5 ]
(R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate
Similarity: 0.86
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.84
[ 144163-85-9 ]
tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate
Similarity: 0.83
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.83
[ 156474-22-5 ]
tert-Butyl ((R)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate
Similarity: 0.88
[ 478646-28-5 ]
(R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate
Similarity: 0.86
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.84
[ 144163-85-9 ]
tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate
Similarity: 0.83
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.83
[ 875444-08-9 ]
(4S,5R)-5-(3,5-Bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one
Similarity: 0.83